Rabadi Meheroz H, Just Kimberly, Xu Chao
Oklahoma City Veterans Affairs Medical Center.
Department of Neurology, Oklahoma University Health Sciences Center, Oklahoma.
Disabil Rehabil. 2022 Aug;44(16):4415-4420. doi: 10.1080/09638288.2021.1907621. Epub 2021 Apr 7.
Patients who adhere to their disease-modifying therapies (DMTs) have a lower rate of MS-related relapses and disability. We sought to determine the adherence rate to DMTs and the association between adherence to DMTs and employment in patients with multiple sclerosis (MS).
One hundred and forty-two patients with MS who were periodically followed in our clinic between January 2000 and January 2020. We compared three groups of patients, defined according to their adherence to DMTs (non-adherent; poorly adherent; adherent), on their obtaining paid employment.
Forty-seven MS patients (33.1%) were non-adherent to any DMT medication, while 88 MS patients (62.0%) demonstrated good and 7 (4.9%) poor adherences. More patients in the good-adherence group were in paid employment 42.0% compared to 23.4% in the non-adherent group ( = 0.587) after controlling for potential co-founders.
In this study veterans who adhered to their DMTs were 2.4 times more likely to be in paid-employment compared to non- or poorly-adherent patients. The clinical significance of this study is to encourage MS patients to adhere to their DMTs as a motivating factor of being in paid-employment.Implications for rehabilitationWhat is known about this subject? In the setting of a randomized controlled trial adherence rates reported for different injectable DMTs vary from 79-85% for once a week interferon beta-1a (IM IFNb-1a) to 49-78% for other injectable DMTs.•What are the new findings and/or impact on clinical practice?•Paid employment was more common among veterans whose adherence to DMTs was good (42.0% employed) or poor (42.9%) than among those who were non-adherent (23.4%). Veterans who adhered to DMTs were also younger, had less severe MS, and displayed less cognitive and physically impairment than those who did not adhere.•Being employed can act as a motivating factor to encourage adherence to treatment aimed at preventing accumulation of mental and physical disabilities.
坚持疾病修正治疗(DMT)的患者多发性硬化症(MS)相关复发和残疾率较低。我们试图确定MS患者对DMT的依从率以及DMT依从性与就业之间的关联。
2000年1月至2020年1月期间在我们诊所定期随访的142例MS患者。我们根据患者对DMT的依从性(不依从;依从性差;依从)将患者分为三组,比较他们获得有偿工作的情况。
47例MS患者(33.1%)不依从任何DMT药物,88例MS患者(62.0%)依从性良好,7例(4.9%)依从性差。在控制潜在混杂因素后,依从性良好组中有更多患者从事有偿工作,比例为42.0%,而不依从组为23.4%(Z = 0.587)。
在本研究中,与不依从或依从性差的患者相比,坚持DMT的退伍军人从事有偿工作的可能性高2.4倍。本研究的临床意义在于鼓励MS患者坚持DMT,将其作为从事有偿工作的一个激励因素。
康复启示
关于这个主题已知的信息有哪些?在一项随机对照试验中报告的不同注射用DMT的依从率有所不同,从每周一次的干扰素β-1a(IM IFNb-(此处原文有误,应为1a))的79 - 85%到其他注射用DMT的49 - 78%不等。
新发现和/或对临床实践的影响是什么?
在坚持DMT良好(42.0%就业)或差(42.9%)的退伍军人中,有偿工作比不依从者(23.4%)更为常见。坚持DMT的退伍军人也更年轻,MS病情较轻,并且与不坚持的退伍军人相比,认知和身体损伤更少。
就业可以作为一种激励因素,鼓励坚持旨在预防精神和身体残疾积累的治疗。